Ontario announced plans on Thursday to produce a medical isotope at the Darlington Nuclear Generation Station.
The isotope is used by two Ottawa-area companies to produce a drug called TheraSphere.
It’s already been provided to more than 100,000 liver cancer patients worldwide.
Matthew Bingley has the story.
For more info, please go to https://globalnews.ca
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #Ontario #science